» Articles » PMID: 20009778

Characteristics of Insured Patients with Persistent Gaps in Diabetes Care Services: the Translating Research into Action for Diabetes (TRIAD) Study

Overview
Journal Med Care
Specialty Health Services
Date 2009 Dec 17
PMID 20009778
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although preventing diabetes complications requires long-term management, little is known about which patients persistently fail to get recommended care.

Objective: To determine the frequency and correlates of persistent, long-term gaps in diabetes care.

Method: : The study population included 8392 patients with diabetes. Patient surveys and medical records from 10 health plans over 3 years provided data on socioeconomic characteristics, access to care, social support, and mental and physical health, and diabetes preventive care services. We defined a "persistent gap" as a participant's missing a preventive care service for the entire 3 years. Services considered included hemoglobin A1c, cholesterol, and albuminuria tests, and foot and dilated eye examinations.

Results: Thirty percent of participants had at least 1 persistent gap. The most common gaps were lipid testing (11.6%), microalbuminuria testing (9.7%), and eye examinations (9.0%). Persistent gaps were 18% to 42% higher for young patients, lean persons, those with low income, employed persons, smokers, those with diabetes less than 5 years, and patients with none or 1 comorbid conditions. Sex, education, marital status, family demands, transportation, trust in physicians, and mental health were not associated with gaps in care.

Conclusions: Persistent gaps in diabetes care are common even among insured patients. Patients with lower income, younger age, fewer years of diabetes, having fewer comorbidities, taking fewer medications, and poor health behaviors are vulnerable to persistent gaps in care and a group who warrant targeted interventions to improve preventive diabetes care.

Citing Articles

Prevalence of cardiovascular disease among Asian, Pacific Islander and multi-race populations in Hawai'i and California.

Waitzfelder B, Palaniappan L, Varga A, Frankland T, Li J, Daida Y BMC Public Health. 2023; 23(1):885.

PMID: 37189145 PMC: 10184427. DOI: 10.1186/s12889-023-15795-5.


Sex Disparities in Cardiovascular Risk Factor Assessment and Screening for Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review.

de Jong M, Peters S, de Ritter R, van der Kallen C, Sep S, Woodward M Front Endocrinol (Lausanne). 2021; 12:617902.

PMID: 33859615 PMC: 8043152. DOI: 10.3389/fendo.2021.617902.


Systematic review and meta-analysis of patient race/ethnicity, socioeconomics, and quality for adult type 2 diabetes.

Lee W, Lloyd J, Giuriceo K, Day T, Shrank W, Rajkumar R Health Serv Res. 2020; 55(5):741-772.

PMID: 32720345 PMC: 7518886. DOI: 10.1111/1475-6773.13326.


Young onset type 2 diabetic patients might be more sensitive to metformin compared to late onset type 2 diabetic patients.

Li F, Liu B, Yin G, Zhang D, Zhai X, Chen M Sci Rep. 2017; 7(1):16382.

PMID: 29180640 PMC: 5703958. DOI: 10.1038/s41598-017-16658-x.


Effectiveness of seasonal influenza vaccination in patients with diabetes: protocol for a nested case-control study.

Casanova L, Cortaredona S, Gaudart J, Launay O, Vanhems P, Villani P BMJ Open. 2017; 7(8):e016023.

PMID: 28821521 PMC: 5629692. DOI: 10.1136/bmjopen-2017-016023.


References
1.
Vijan S, Hofer T, Hayward R . Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 2000; 283(7):889-96. DOI: 10.1001/jama.283.7.889. View

2.
Selby J, Swain B, Gerzoff R, Karter A, Waitzfelder B, Brown A . Understanding the gap between good processes of diabetes care and poor intermediate outcomes: Translating Research into Action for Diabetes (TRIAD). Med Care. 2007; 45(12):1144-53. DOI: 10.1097/MLR.0b013e3181468e79. View

3.
. Preventive-care practices among persons with diabetes--United States, 1995 and 2001. MMWR Morb Mortal Wkly Rep. 2002; 51(43):965-9. View

4.
. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA. 2003; 290(16):2159-67. PMC: 2622725. DOI: 10.1001/jama.290.16.2159. View

5.
Gregg E, Geiss L, Saaddine J, Fagot-Campagna A, Beckles G, Parker C . Use of diabetes preventive care and complications risk in two African-American communities. Am J Prev Med. 2001; 21(3):197-202. DOI: 10.1016/s0749-3797(01)00351-8. View